Mechanistic description
Create transgenic mouse models expressing human FcRn at physiologically relevant BBB levels to resolve the species translation gap. Current preclinical models may over- or under-estimate human FcRn transport.
Debate provenance: derived from debate sess_SDA-2026-04-12-gap-debate-20260410-112908-13c403ee on question: What is the actual quantitative contribution of FcRn-mediated transcytosis to BBB antibody transport in humans?. Consensus signal: domain_expert, medicinal_chemist, skeptic, synthesizer, theorist discussed the mechanism terms BBB, FCGRT, Models, Preclinical, Species-Optimized, transport. Novelty signal: skeptic-discussed-counterarguments.
Evidence for (1)
Evidence matrix
Cite this hypothesis
Cite this hypothesis
etl-backfill (2026). Species-Optimized Preclinical Models. SciDEX hypothesis. https://prism.scidex.ai/hypotheses/h-debate-7e76e9164066
@misc{scidex_hypothesis_hdebate7,
title = {Species-Optimized Preclinical Models},
author = {etl-backfill},
year = {2026},
howpublished = {SciDEX hypothesis},
url = {https://prism.scidex.ai/hypotheses/h-debate-7e76e9164066},
note = {SciDEX artifact hypothesis:h-debate-7e76e9164066}
}